BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 3319387)

  • 21. [Serum levels of the CA-125 antigen in the diagnosis of ovarian neoplasms].
    Sopracordevole F; Finco B; Scarabelli C; Campagnutta E; Alimena C; Perin A
    Minerva Ginecol; 1985 Oct; 37(10):589-96. PubMed ID: 3866146
    [No Abstract]   [Full Text] [Related]  

  • 22. [Preliminary study on detecting the CA 125 value in endometrial washings].
    Chen DX; Schwartz PE
    Zhonghua Fu Chan Ke Za Zhi; 1987 Sep; 22(5):288-90, 312. PubMed ID: 3481694
    [No Abstract]   [Full Text] [Related]  

  • 23. [CA125 in patients with pleural effusion--in comparison with ascites patients].
    Kawabe T; Hirano M; Mohri M; Sugimoto T; Nagata Y; Hisada M; Muto H; Unuma T; Momose T; Naka H
    Rinsho Byori; 1987 Aug; 35(8):905-9. PubMed ID: 3480365
    [No Abstract]   [Full Text] [Related]  

  • 24. [Clinical significance of galactosyltransferase associated with tumor (GAT), a new tumor marker for ovarian cancer--with special reference to the discrimination between ovarian cancer and endometriosis].
    Nozawa S; Udagawa Y; Ito K; Nishimura H; Yakushiji M; Shiota M; Noda K; Yajima M; Ohkura H; Murae M
    Gan To Kagaku Ryoho; 1994 Mar; 21(4):507-16. PubMed ID: 8129392
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Tumor markers in the diagnosis of tumors in the subhepatic area].
    Dufek V; Petrtýl J; Klener P; Chmel J
    Vnitr Lek; 1994 Jun; 40(6):350-3. PubMed ID: 8073643
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ancillary methods for the detection of recurrent urothelial neoplasia.
    Ross JS; Cohen MB
    Cancer; 2000 Apr; 90(2):75-86. PubMed ID: 10794156
    [No Abstract]   [Full Text] [Related]  

  • 27. CA 125 levels measured in different phases of the menstrual cycle in screening for endometriosis.
    O'Shaughnessy A; Check JH; Nowroozi K; Lurie D
    Obstet Gynecol; 1993 Jan; 81(1):99-103. PubMed ID: 8416469
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A clinical evaluation of CA 125 levels in serum, ascites and pleural effusion].
    Jibiki K; Demura R; Abe Y; Odagiri E; Demura H
    Gan No Rinsho; 1987 Nov; 33(14):1756-62. PubMed ID: 3480363
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Diagnosis of the recurrence of epithelial ovarian cancer with the tumor marker CA 125].
    Sevelda P; Wagner G
    Wien Klin Wochenschr; 1987 Nov; 99(21):768-70. PubMed ID: 3480655
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Tumor markers in uterine cancers].
    Fukasawa I; Kousaka N; Kun Z; Inaba N
    Gan To Kagaku Ryoho; 2002 Feb; 29(2):333-40. PubMed ID: 11865645
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Serum level of the tumor marker CA 125 in ovarian pathology].
    Bagni B; Pansini FS; Feggi LM; Prandini N; Mollica G
    Radiol Med; 1987 Nov; 74(5):448-50. PubMed ID: 3479814
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Flow cytometric analysis of T and Tn epitopes on chronic lymphocytic leukemia cells.
    Aller CT; Kucuk O; Springer GF; Gilman-Sachs A
    Am J Hematol; 1996 May; 52(1):29-38. PubMed ID: 8638608
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endometriosis.
    Hammond CB; Rock JA
    Obstet Gynecol; 1977 Mar; 49(3):383. PubMed ID: 840471
    [No Abstract]   [Full Text] [Related]  

  • 34. Mining medical data: a case study of endometriosis.
    Wang YF; Chang MY; Chiang RD; Hwang LJ; Lee CM; Wang YH
    J Med Syst; 2013 Apr; 37(2):9899. PubMed ID: 23321969
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence on endometriosis. Elitism about randomised controlled trials is inappropriate.
    Redwine D; Mann CH; Wright JT
    BMJ; 2000 Oct; 321(7268):1077-8. PubMed ID: 11053191
    [No Abstract]   [Full Text] [Related]  

  • 36. Recurrent endometriosis.
    Wheeler JM; Malinak LR
    Contrib Gynecol Obstet; 1987; 16():13-21. PubMed ID: 3319387
    [No Abstract]   [Full Text] [Related]  

  • 37. Serum CA-125 levels in women with endometriosis.
    Grover S; Koh H
    Aust N Z J Obstet Gynaecol; 1990 Aug; 30(3):279-80. PubMed ID: 2256870
    [No Abstract]   [Full Text] [Related]  

  • 38. [Place of carbohydrate antigens in the spectrum of protein tumor markers in patients with tumors at different sites].
    Reznikov IuP; Ul'ianov VI; Variukhin AS; Vanin AI; Vorontsova LP
    Vopr Onkol; 1988; 34(1):51-6. PubMed ID: 3422524
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Immunologic diagnosis of cancer--tumor markers].
    Kawai T
    Gan No Rinsho; 1989 Jan; Spec No():13-8. PubMed ID: 2915470
    [No Abstract]   [Full Text] [Related]  

  • 40. [Clinical significance of present tumor markers].
    Ohkura H
    Gan To Kagaku Ryoho; 1993 May; 20(7):843-9. PubMed ID: 7683865
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.